DESERT FLAME

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark DESERT FLAME was filed as Word mark on 02/09/2021 at the World Intellectual Property Organization.

Trademark Details Last update: February 28, 2023

Trademark form Word mark
File reference 1587491
Countries Brazil European Community United Kingdom New Zealand
Base trademark AU No. 2153119, February 3, 2021
Application date February 9, 2021
Expiration date February 9, 2031

Trademark owner

Suite 2, Level 2,
66 Kings Park Road
AU

Trademark representatives

GPO Box 1285 Melbourne VIC 3001 AU

goods and services

05 Pharmaceutical compositions; chemical, pharmaceutical, disinfectant, antiseptic and veterinary products and preparations included in this class; pharmaceutical preparations contained in transdermal patches; food supplements; medicinal herbs, balms and creams and ointments for medicinal purposes; oils for medical purposes; tinctures for medical purposes; natural medicinal extracts; drugs for medical purposes; pharmaceutical preparations for skin care; medical syrups and emulsions; herbal extracts for medical purposes; herbal medicine; medical products for pain prevention and relief; adjuvants for medical purposes; medicated candy; medicated lozenges; medicinal plant compounds for use as dietary supplements; liquid medicaments; ointments for pharmaceutical purposes; dietetic food preparations and supplements adapted for medical use; medical cannabis and derivatives thereof; therapeutic agents (medical); cannabis products for medical purposes, including oils, salves, concentrated pastes, therapeutic creams and tinctures containing cannabinoids; infusions for medicinal purposes made from herbs; medicinal herbs; herbal preparations for medical purposes; pharmaceutical preparations for human use; pharmaceutical preparations for health care; pharmaceutical preparations for nasal use; pharmaceutical preparations for oral use; pharmaceutical preparations for topical use; pharmaceutical preparations in the form of foams, gels, emulsions, elixirs, lotions, ointments, tinctures, creams, liquids, oils, lozenges, tablets, capsules, sprays and skin patches; terpenoids, cannabidiol, and cannabinoids for medical purposes; pharmaceutical preparations and substances for the prevention, management and treatment of disorders of the brain, skin care, dermatological conditions, bone conditions, cancer, depressive illness, arthritis, joint related diseases, arthrosis, muscle tension, rheumatism, pain, chronic pain, neuropathic pain, cancer-related pain, visceral pain, migraine, orofacial pain, pain or spasticity associated with traumatic spinal cord injury, epilepsy, multiple sclerosis, palliative care, wasting, chronic fatigue, cystic fibrosis, cirrhosis, anorexia and bulimia, cachexia, anxiety and mood disorders, autism disorders and aspergers, lou gehrig's disease, asthma, adhd, amyloidosis, back pain, schizophrenia, bipolar disorder, crohn's disease, nausea and vomiting, hiv/aids, sciatica, osteoarthritis, chemotherapy induced nausea and vomiting, chronic regional pain syndrome, neuropathic pain, opioid dependence, parkinson's disease, ptsd, rheumatoid arthritis, spasticity from neurological conditions, depression, dystonia, fibromyalgia, insomnia and sleep disturbance, dementia, diabetes, kidney disease, endometriosis, emphysema, acne and eczema, glaucoma, gout and arthropathy, heart disease, high blood pressure, hepatitis c, inflammation, inflammatory bowel disease, jaundice, liver disease, lupus, menopause, mesothelioma, obesity, osteoporosis, osteoarthritis, phantom pain, pneumonia, pancreatitis, personality disorders, restless leg syndrome, scoliosis, shingles, sickle cell disease, tinnitus, tendinitis, tuberculosis, ulcers, yeast infection, yellow fever; pain killers (pharmaceuticals); medicated preparations for oral and sublingual use including oil and buccal formulations; flower and herbal substances for smoking, vaping and inhalation for medical purposes; mucosal sprays; suppositories; liposomal and emulsion preparations for medical purposes; skin and transdermal patches; tonics (medicine); all of the aforesaid goods excluding probiotic products derived from cultured microorganisms

Trademark history

Date Document number Area Entry
February 21, 2023 2023/9 Gaz EM Rejection
March 22, 2022 2022/12 Gaz BR Rejection
November 30, 2021 2021/48 Gaz NZ Rejection
November 2, 2021 2022/1 Gaz AU RAW: Partial Ceasing Effect
September 9, 2021 2021/36 Gaz GB Rejection
September 6, 2021 2021/37 Gaz EM Rejection
February 9, 2021 2021/14 Gaz AU Registration

ID: 141587491